Detection of metastatic disease in patients with uveal melanoma using positron emission tomography

被引:22
作者
Francken, A. B.
Fulham, M. J.
Millward, M. J.
Thompson, J. F.
机构
[1] Royal Prince Alfred Hosp, Sydney Melanoma Unit, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Dept PET & Nucl Med, Sydney, NSW 2006, Australia
[3] Univ Sydney, Dept Med Oncol, Sydney, NSW 2006, Australia
[4] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia
[5] Univ Sydney, Discipline Surg, Sydney, NSW 2006, Australia
来源
EJSO | 2006年 / 32卷 / 07期
关键词
positron emission tomography; uveal melanoma; metastasis; liver;
D O I
10.1016/j.ejso.2006.04.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Positron emission tomography with [F-18]fluorodeoxyglucose (FDG-PET) is of proven value in the detection of metastases in patients with cutaneous melanoma. However, little is known about its value in uveal melanoma (UM). In this study the results of FDG-PET in patients with UM were evaluated. Methods: Patients with UM recorded in the Sydney Melanoma Unit database who had been assessed with FDG-PET were selected. Comparative data (imaging or histopathology) providing information about metastatic disease were obtained within 14 weeks of the FDG-PET study and compared with the FDG-PET result. Sensitivity, specificity, accuracy, and positive and negative predictive values for the detection of liver metastases (LMs) by FDG-PET were calculated. Results: FDG-PET was performed in 22 patients with UM between April 1993 and March 2003. The presence of at least one focus of metastatic melanoma was confirmed in 14 of 18 patients with positive FDG-PET, and three of four negative FDG-PET studies were confirmed. LMs were demonstrated by FDG-PET in 17 patients. In 15 of these patients this finding was confirmed with anatomical imaging. In two patients LMs indicated by FDG-PET initially appeared to be false positive, but in one of them the diagnosis was confirmed after longer follow-up. Seven of the confirmed lesions were isolated LMs. For LMs FDG-PET showed sensitivity, specificity and accuracy of 100%, 67% and 90% respectively, a positive predictive value of 88% and a negative predictive value of 100%. Conclusion: FDG-PET is a valuable investigation for the detection of LMs in UM patients. It appears to be particularly useful in the detection of isolated LMs that are potentially resectable. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:780 / 784
页数:5
相关论文
共 27 条
[1]  
Albert DM, 1996, ARCH OPHTHALMOL-CHIC, V114, P107
[2]  
Alexander HR, 2003, CLIN CANCER RES, V9, P6343
[3]   The role of surgery for patients with metastatic melanoma [J].
Allen, PJ ;
Coit, DG .
CURRENT OPINION IN ONCOLOGY, 2002, 14 (02) :221-226
[4]   Isolation perfusion of the liver [J].
Carroll, NM ;
Alexander, HR .
CANCER JOURNAL, 2002, 8 (02) :181-193
[5]  
Collaborative Ocular Melanoma Study Group, 2001, Arch Ophthalmol, V119, P670
[6]   Developments in the management of uveal melanoma [J].
Damato, B .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (06) :639-647
[7]   Positron emission tomography in the detection and management of metastatic melanoma [J].
Damian, DL ;
Fulham, MJ ;
Thompson, E ;
Thompson, JF .
MELANOMA RESEARCH, 1996, 6 (04) :325-329
[8]   Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group report 23 [J].
Diener-West, M ;
Reynolds, SM ;
Agugliaro, DJ ;
Caldwell, R ;
Cumming, K ;
Earle, JD ;
Green, DL ;
Hawkins, BS ;
Hayman, J ;
Jaiyesimi, I ;
Kirkwood, JM ;
Koh, WJ ;
Robertson, DM ;
Shaw, JM ;
Thoma, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2438-2444
[9]   METASTATIC UVEAL MELANOMA - PRETHERAPY SERUM LIVER-ENZYME AND LIVER-SCAN ABNORMALITIES [J].
DONOSO, LA ;
BERD, D ;
AUGSBURGER, JJ ;
MASTRANGELO, MJ ;
SHIELDS, JA .
ARCHIVES OF OPHTHALMOLOGY, 1985, 103 (06) :796-798
[10]   Whole body PET/CT for initial staging of choroidal melanoma [J].
Finger, PT ;
Kurli, M ;
Reddy, S ;
Tena, LB ;
Pavlick, AC .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (10) :1270-1274